Skip to content
zameds

Aprepitant (Aprepitant Eurolab, Aprepitant Combipack Eurolab, Apemeze)

Aprepitant

Eurolab (Pty) Ltd

S4

Registration

Applicant
Eurolab (Pty) Ltd
Registrations
5
Schedule source
Consolidated Schedules 06 July 2026

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Aprepitant 80 eurolab

EACH CAPSULE CONTAINS: APREPITANT 80,0 mg

8053023453/5.7.2/0234RegisteredS4None
Aprepitant 125 eurolab

EACH CAPSULE CONTAINS: APREPITANT 125,0 mg

12553023553/5.7.2/0235RegisteredS4None
Aprepitant combipack eurolab

EACH CAPSULE CONTAINS: APREPITANT 80,0 mg or 125,0 mg

Not listed53023653/5.7.2/0236RegisteredS4None
Apemeze 80 MG

EACH CAPSULE CONTAINS APREPITANT 80,0 mg

80 mg56006256/5.7.2/0062RegisteredS4None
Apemeze 125 MG

EACH CAPSULE CONTAINS APREPITANT 125,0 mg

125 mg56006356/5.7.2/0063RegisteredS4None

Regulatory status

Where S4 sits on the scale

Prescription-only medicine.

Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S4, matched to the Consolidated Schedules by ingredient, confidence high.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.

Consolidated Schedules listings for Aprepitant

  • S4: Aprepitant

    Consolidated Schedules 06 July 2026, line 5335

Pharmacological class: Anti-emetics and antivertigo preparations. (class 5.7.2)

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

C23H21F7N4O3534.40 g/mol

3-[[(2R,3S)-2-[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-1,4-dihydro-1,2,4-triazol-5-one

Drag to rotate. Structure from PubChem CID 135413536.

SAHPRA documents

SAHPRA has not published a professional information or patient information leaflet for this product.

Background

Loading...
Loading Wikipedia summary

Research articles

Loading...
Loading PubMed articles